Novavax outlines $400M 2026 revenue framework while targeting cash runway into 2029
Source: Seeking Alpha ·
Read the full story at Seeking Alpha
Shared from the GodsView world desk: live wires next to a globe of flights, ships, fires, and quakes.
More from the world desk
- Latigo Biotherapeutics, Inc. GAAP EPS of -$0.55 beats by $0.12 Seeking Alpha
- Middleby outlines 2026 guidance raise to $7.13-$7.29 EPS as CEO transition set for April 1, 2027 Seeking Alpha
- Albertsons ordered to pay $900M in opioid crisis case Seeking Alpha
- Israel’s Election Ended With No Clear Winner. These Parties Are Trying to Form a Coalition. NY Times
- Ralph Lauren outlines fiscal 2027 revenue growth of 6% to 7% with 80 to 100 bps operating margin expansion Seeking Alpha
- Korro Bio GAAP EPS of -$0.98 beats by $0.38 Seeking Alpha